Glioblastoma
What's New
Last Posted: May 02, 2024
- Profiling the molecular and clinical landscape of glioblastoma utilizing the Oncology Research Information Exchange Network brain cancer database.
Alexandra N Demetriou et al. Neurooncol Adv 2024 6(1) vdae046 - Survival prediction of glioblastoma patients using modern deep learning and machine learning techniques.
Samin Babaei Rikan et al. Sci Rep 2024 14(1) 2371 - Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme.
Gabriel Cerono et al. J Healthc Inform Res 2024 8(1) 1-18 - The application value of deep learning in the background of precision medicine in glioblastoma.
Pengyu Chen et al. Sci Prog 2024 107(1) 368504231223353 - The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
Vincenzo Di Nunno et al. Cells 2024 13(1) - Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme
A Sosinsky et al, Nature Medicine, January 11, 2024 - Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis.
Marta Padovan et al. Eur J Cancer 2023 191112959 - Deep Learning Approaches for Glioblastoma Prognosis in Resource-Limited Settings: A Study using Basic Patient Demographic, Clinical, and Surgical Inputs.
Marc Ghanem et al. World Neurosurg - The Glioma-IRE project - Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach.
Veronica Villani et al. Journal of translational medicine 2023 21(1) 215 - Integrated molecular and clinical analysis of BRAF-mutant glioma in adults.
Karisa C Schreck et al. NPJ precision oncology 2023 7(1) 23
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: